These results are consistent with the effects of MEOX2 on glioma, and CTSS re-expression in MEOX2 depleted cells could partially restore the capacities of cell proliferation and motility in vitro and in vivo, suggesting that MEOX2-CTSS axis facilitated the malignant progression of glioma by above molecular mechanisms. The gene discussed is CTSS; the disease is glioma.